首页> 外文会议>International Conference on Chemistry, Chemical Process and Engineering >Molecular Docking and ADME-Toxicity Studies of Potential Compounds of Medicinal Plants Grown In Indonesia as An Anti-rheumatoid Arthritis
【24h】

Molecular Docking and ADME-Toxicity Studies of Potential Compounds of Medicinal Plants Grown In Indonesia as An Anti-rheumatoid Arthritis

机译:印度尼西亚生长中药潜在化合物的分子对接与Adape毒性研究作为抗类风湿性关节炎

获取原文

摘要

Rheumatoid arthritis (RA) is an autoimmune disease with recurrent bone destruction around the joints that could lead to permanent joint damage. DMARDs (Disease Modifying Anti-Rheumatoid Drugs) and NSAIDs (Non-Steroid Anti-Inflammatory Drugs) are the RA therapies with many side effects on long term use. Based on the ethnomedicine, there are many plants that could be found in Indonesia that contain the potential compounds as alternative RA therapies. The aim of this study is to assess the potential of compounds of various medicinal plants against multiple proteins that play an important role on RA through the molecular docking study and pharmacokinetic prediction. Hesperidin, EGCG (Epigallocatechin gallate), and mangiferin showed higher activity compared to the other compounds against TACE (TNF-α converting enzyme) which play an important role in the inhibition of TNF-α. Inhibition on it could suppress macrophage cell and T-cell activity by suppressing the regulation of cytokine secretion against inflammation. Furthermore, hesperidin, EGCG, and mangiferin did not show effects on CYP450 (cytochrome P450). Modification of drug delivery system must be done to increase the bioavailability of the compounds. It can be concluded that hesperidin, EGCG, and mangiferin are potential to be developed as an RA therapy with a modification of drug delivery system. This study suggest the encapsulation method using liposome as the drug carrier, which is suitable with the charactheristic of hesperidine, EGCG, and mangiferin.
机译:类风湿性关节炎(RA)是一种自身免疫性疾病,其关节周围具有可反复性的骨破坏,可能导致永久性接头损坏。 DMARDS(疾病改性抗类风湿药物)和NSAIDs(非类固醇抗炎药)是RA疗法,长期使用具有许多副作用。基于乙基审核,有许多植物可以在印度尼西亚中发现,该植物含有潜在化合物作为替代RA疗法。本研究的目的是评估各种药用植物化合物对多种蛋白质的潜力,通过分子对接研究和药代动力学预测在RA上发挥着重要作用。 Hesperidin,EGCG(EpigallocateChin Gallate),与颅内素相比,与针对TNF-α的抑制作用重要作用的其他化合物相比,Mangiferin显示出更高的活性。通过抑制对炎症的细胞因子分泌的调节,抑制它可以抑制巨噬细胞和T细胞活性。此外,Hesperidin,EGCG和Mangiferin没有显示对CYP450的影响(细胞色素P450)。必须进行药物输送系统的改性以增加化合物的生物利用度。可以得出结论,伊斯敏蛋白,EGCG和Mangiferin可能被开发为具有药物递送系统的修饰的RA治疗。本研究表明,使用脂质体作为药物载体的封装方法,其适用于哈培胺,EGCG和Mangiferin的Charactristic。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号